| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $35.7B | $36.3B | $33.1B | $28.1B | $22.9B | $23.6B | $32.9B | $32.8B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $0.7B | $0.7B | $0.7B | $0.6B | $0.6B | $0.6B | $0.7B | $0.7B |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | $6.5B | $5.0B | $3.4B | $2.4B | $4.0B | $4.2B |
| Net Income | $3.4B | $4.5B | $4.2B | $3.4B | $1.9B | $-10.5B | $-10.1B | $2.1B |
| EPS (Basic) | $2.38 | $3.14 | $2.95 | $2.43 | $1.34 | $-7.57 | $-7.32 | $1.54 |
| EPS (Diluted) | $2.35 | $3.11 | $2.91 | $2.39 | $1.32 | $-7.57 | $-7.32 | $1.53 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $54.9B | $48.9B | $48.0B | $43.1B | $41.5B | $42.4B | $56.3B | $70.5B |
| Current Assets | $19.5B | $18.6B | $17.7B | $15.0B | $12.7B | $12.9B | $15.5B | $15.7B |
| Cash & Equivalents | $3.0B | $3.5B | $2.9B | $1.7B | $1.8B | $0.8B | $1.1B | $1.4B |
| Total Liabilities | $27.6B | $26.6B | $26.6B | $25.1B | $26.2B | $29.9B | $32.1B | $33.9B |
| Current Liabilities | $14.7B | $12.8B | $13.4B | $12.0B | $10.4B | $10.5B | $13.1B | $13.5B |
| Stockholders' Equity | $26.1B | $21.1B | $20.2B | $17.7B | $15.0B | $12.1B | $23.8B | $36.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $6.5B | $6.6B | $6.6B | $3.7B | $4.7B | $2.9B | $5.4B | $5.7B |
| Investing Cash Flow | $-1.4B | $-3.1B | $-2.8B | $-1.4B | $-0.9B | $-2.4B | $-2.0B | $-1.0B |
| Capital Expenditures | $1.7B | $1.9B | $1.9B | $1.6B | $1.1B | $1.1B | $1.7B | $2.2B |
| Financing Cash Flow | $-5.6B | $-2.8B | $-2.5B | $-2.4B | $-2.8B | $-0.9B | $-3.7B | $-5.0B |